Type | Private |
---|---|
Industry | Biotechnology, Life Science, Contract Research Organization |
Founded | 1990 |
Headquarters | San Diego, California, United States |
Services | clinical development, preclinical development, drug discovery, discovery tools, chemistry |
Employees | 500+ |
Subsidiaries | in Russia, Ukraine |
Website | chemdiv.com |
Chemical Diversity (ChemDiv) is a fully integrated Contract research organization headquartered in San Diego, CA, with subsidiaries in Russia and Ukraine. It provides pharmaceutical and biotech companies integrated discovery and development solutions for their R&D programs. ChemDiv's services cover a range of disciplines needed to bring a new project in CNS, oncology, inflammation, metabolic, infectious and other diseases from identification of a biological target (protein expression, assay development etc.) to clinical drug candidates (ADME/DMPK, toxicity and safety studies, efficacy models etc.) to Proof of Concept drug candidate (Phase I and II) and to the market.
ChemDiv started in 1990 as a chemistry provider and has moved to a full service CRO since. Among its partners are Eli Lilly[1], Novartis[2][3], Dendreon[4], Merck KGaA[5], Solvay Pharmaceuticals [6], Bayer, etc.